BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Argos Therapeutics, Inc. (Formerly Merix Bioscience) 

4233 Technology Drive

Durham  North Carolina  27704  U.S.A.
Phone: 919-287-6300 Fax: 919-287-6301


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Duke University  Exclusive license to the RNA based vaccine technology.

Rockefeller University  Exclusive worldwide rights to technology developed at Rockefeller relating to generation of dendritic cells.

Baylor University  Clinical and preclinical research in Lupus.

Kirin Brewery Co., Ltd.  The companies will collaborate to develop and commercialize dendritic cell vaccines, initially in the areas of cancer and infectious diseases.

Erlangen University  Clinical and preclinical research in Melanoma.





 Company News
Argos Therapeutics, Inc. (ARGS) To Present At The World Stem Cells Regenerative Medicine Congress 2015 5/20/2015 2:07:09 PM
Argos Therapeutics, Inc. (ARGS) Reports First Quarter 2015 Financial Results And Operational Highlights 5/15/2015 8:35:52 AM
Argos Therapeutics, Inc. (ARGS) Provides Update On Enrollment Progress For Ongoing Pivotal Phase III ADAPT Clinical Trial 5/14/2015 7:27:43 AM
Argos Therapeutics, Inc. (ARGS) To Present At 36th American Society For Apheresis Annual Meeting 5/8/2015 8:25:08 AM
Argos Therapeutics, Inc. (ARGS) To Hold First Quarter 2015 Financial Results Conference Call On Thursday, May 14, 2015 5/8/2015 7:55:00 AM
Argos Therapeutics, Inc. (ARGS) Recognized For Economic Development At The 17th Annual Triangle CREW Champion Awards 4/23/2015 10:47:28 AM
Argos Therapeutics, Inc. (ARGS) Announces Publication Of Data From Phase 2 Clinical Trial Of AGS-003 Fully Personalized Immunotherapy For Treatment Of Metastatic Renal Cell Carcinoma (mRCC) 4/21/2015 8:00:06 AM
Argos Therapeutics, Inc. (ARGS) To Present Update On Pivotal Phase 3 ADAPT Clinical Trial During 2015 ASCO Annual Meeting 4/20/2015 7:47:27 AM
Argos Therapeutics, Inc. (ARGS) Licenses Arcelis Technology Platform To Lummy HK For Development Of Personalized Immunotherapies To Treat Cancer In China 4/15/2015 4:01:36 PM
Argos Therapeutics, Inc. (ARGS) To Present At The 14th Annual Needham Healthcare Conference 4/8/2015 8:09:18 AM
12345678910...